Back
Fulcrum Therapeutics Stock Price Chart
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
1
FULC
Fulcrum Therapeutics
Last Price:
3.51
Seasonality Move:
-0.93%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing slight selling pressure.
Fulcrum Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.33 | Sell |
| 20-day SMA: | 7.42 | Sell |
| 50-day SMA: | 8.19 | Sell |
| 200-day SMA: | 7.89 | Sell |
| 8-day EMA: | 4.87 | Sell |
| 20-day EMA: | 6.61 | Sell |
| 50-day EMA: | 7.59 | Sell |
| 200-day EMA: | 7.49 | Sell |
Fulcrum Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.33 | Sell |
| Relative Strength Index (14 RSI): | 24.25 | Sell |
| Chaikin Money Flow: | -65859 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.54 - 10.08) | Sell |
| Bollinger Bands (100): | (6.37 - 9.11) | Sell |
Fulcrum Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Fulcrum Therapeutics Stock
Is Fulcrum Therapeutics Stock a Buy?
- Fulcrum Therapeutics share price is 3.44 while FULC 8-day simple moving average is 5.33, which is a Sell signal.
- The stock price of FULC is 3.44 while Fulcrum Therapeutics 20-day SMA is 7.42, which makes it a Sell.
- Fulcrum Therapeutics 50-day simple moving average is 8.19 while FULC share price is 3.44, making it a Sell technically.
- FULC stock price is 3.44 and Fulcrum Therapeutics 200-day simple moving average is 7.89, creating a Sell signal.
FULC Technical Analysis vs Fundamental Analysis
Sell
1
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy or a Sell?
-
Fulcrum Therapeutics stock is rated a Sell
The current Fulcrum Therapeutics [FULC] share price is $3.44. The Score for FULC is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
Fulcrum Therapeutics Stock Info
Market Cap:
214.66M
Price in USD:
3.44
Share Volume:
1.38M
Fulcrum Therapeutics 52-Week Range
52-Week High:
13.70
52-Week Low:
2.87
Sell
1
Fulcrum Therapeutics (FULC)
is a Sell
Fulcrum Therapeutics Share Price Forecast
-
What is the Fulcrum Therapeutics stock price today?
The Fulcrum Therapeutics stock price is 3.44 USD today. -
Will FULC stock go up or go down?
Fulcrum Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Fulcrum Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Fulcrum Therapeutics is overvalued.
Is Fulcrum Therapeutics Stock a Buy?
- Fulcrum Therapeutics share price is 3.44 while FULC 8-day exponential moving average is 4.87, which is a Sell signal.
- The stock price of FULC is 3.44 while Fulcrum Therapeutics 20-day EMA is 6.61, which makes it a Sell.
- Fulcrum Therapeutics 50-day exponential moving average is 7.59 while FULC share price is 3.44, making it a Sell technically.
- FULC stock price is 3.44 and Fulcrum Therapeutics 200-day simple moving average is 7.49, creating a Sell signal.
Fundamental Analysis of Fulcrum Therapeutics
Is Fulcrum Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.15 per share, an increase this year of $1.40 per share, and a decrease next year of $0.79 per share.
Technical Analysis of Fulcrum Therapeutics
Should I short Fulcrum Therapeutics stock?
- FULC Moving Average Covergence Divergence (MACD) indicator is -1.33, suggesting Fulcrum Therapeutics is a Sell
- Fulcrum Therapeutics Relative Strength Index (RSI) is 24.25, which suggest Fulcrum Therapeutics is oversold
- The Bollinger Bands (25) for Fulcrum Therapeutics is (5.54 - 10.08), which suggest Fulcrum Therapeutics is a Sell
- The Bollinger Bands (100) for Fulcrum Therapeutics is (6.37 - 9.11), which suggest Fulcrum Therapeutics is a Sell
* Fulcrum Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.